MedTrix and Novartis bagged the silver 2020 Pharma Choice Award for their interactive web-based augmented reality and chatbot app designed to support patients with polycythemia vera and myelofibrosis.
With the aim of motivating patients to gain deeper knowledge about their treatment and disease, the app has been rolled-out in the EU and is available in three languages: German, French, and Italian.
A testament to our commitment to excellence and innovation, this recognition is no small feat, given that there are hundreds of entries in this category.
Click the link below to know more.
https://www.pm360online.com/2020-pharma-choice-app-silver-winner-medtrix-and-novartis/
Comments
Comments